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Objective: We evaluated how adolescents with or at risk of type 2 diabetes
(T2DM) and their parent/guardians (parents) value health states associated
with T2DM.
Methods: We interviewed overweight/obese [Body Mass Index (BMI) ≥ 85th
percentile], 12–18-yr old adolescents with T2DM, prediabetes, or insulin
resistance (IR) and a parent. The standard gamble (SG) method elicited
preferences (utilities) for seven hypothetical T2DM health states reported on a
scale from 0 (dead) to 1 (perfect health). Adolescent’s current health was
evaluated with the SG and Health Utilities Index (HUI).
Results: There were 70 adolescents and 69 parents. Adolescents were 67.1%
female and 15.5 ± 2.2 yr old; 30% had T2DM, 30% prediabetes, and 40% IR.
Almost half (48.6%) had a BMI > 99th percentile. Parents (83% mothers) were
45.1 ± 7.3 yr old and 75% had at least some college/technical school education.
Adolescents and parents rated T2DM with no complications treated with diet
as most desirable [median (IQR); adolescent 0.72 (0.54, 0.98); parent 1.0 (0.88,
1.0)] and end-stage renal disease as least desirable [adolescent 0.51 (0.31, 0.70);
parent 0.80 (0.65, 0.94)]. However, adolescents’ utilities were significantly
lower (p ≤ 0.001) than parents for all health states assessed. Adolescents’
assessments of their current health with the SG and HUI were not correlated.
Conclusions: Adolescents with or at risk of T2DM rated treatments and
sequelae of diabetes as significantly worse than their parents. These adolescent
utilities should be considered in the evaluation of treatment strategies for
youth with T2DM. Family-based programs for T2DM must also be prepared
to address conflicting preferences in order to promote shared decision-making.
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The prevalence and incidence of type 2 diabetes
(T2DM) among youth have increased (1). Overweight
and obesity among US children also rose between the
1960s and 1990s (2) producing generations of children
at risk for metabolic complications including insulin
resistance (IR), prediabetes, and diabetes (3, 4). Similar
to adults, treatment for T2DM in youth aims to
normalize blood glucose and prevent development of
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microvascular and macrovascular complications (5).
As such, diet and lifestyle changes are standard
components of diabetes treatment and prevention, but
pharmacologic management is often needed (5). Most
adolescents with T2DM are treated with metformin,
insulin, or a combination of the two with individualized
therapy based on presentation and ongoing needs (5).
However, adolescence is a vulnerable period for
children. Recent work suggests that adolescents
with T2DM demonstrate particular difficulty with
adherence to diet and exercise (6), and there are
high rates of attrition from obesity management
programs (7). Racial and ethnic disparities in glycemic
control have also been observed with worse control
seen among non-White youth with diabetes (6, 8, 9).
Little is known about the preferences of adolescents
with or at risk of T2DM and their families for diabetes
treatments, how they value the risk for long-term
complications of diabetes (10, 11), or the cultural and
family context that shapes these preferences.
Health state preferences (also known as utilities) are
a measure of health-related quality of life that describe
an individual’s perception about the ‘desirableness’ or
value of a health condition (12) in contrast to traditional
measuresofhealth-relatedqualityof life,whichdescribe
the impact of a health condition on functional status in
domainssuchasphysicalandemotionalwell-being (13).
Thesepreferencescanbeelicitedwithstandardizedmea-
surement techniques (14) and can then be used in deci-
sion analyses and economic evaluations to guide recom-
mended practice that considers health-related quality of
life (15). For example, in cost-utility analysis, a form of
cost-effectiveness analysis, utilities can be used to adjust
remaining life expectancy for quality of life to calcu-
late QALYs (quality-adjusted life-years) (14). Cost per
QALYs gained as a result of an intervention or program
can then guide decisions about use of resources (14).
On an individual practice level, clarifying the prefer-
ences of adolescents can support patient-centered care
and shared decision-making (16).
Health state preferences in adults, but not ado-
lescents, with T2DM have been described (17–21).
Importantly, Huang et al. have demonstrated that the
cost-effectiveness of treatments for adults with T2DM
is dependent on the assumptions made about patient
preferences for these treatments (21). As preferences
may change from childhood to adulthood (22–24),
elicitation of preferences from adolescents, where
appropriate, has been recommended (22, 23, 25). The
standard gamble (SG), one method for directly eliciting
preferences (14), has been used in adolescents with a
number of chronic disorders (26–31). However, differ-
ences between adolescent and parent-proxy valuation
of pediatric health states raise ongoing questions about
how to approach economic evaluations for adolescent
health and whose values should be considered (23, 25).
In this study, we sought to describe and compare
the preferences of adolescents with or at risk of T2DM
and their parents for key health states associated with
T2DM and its treatments to inform treatment and
prevention strategies. To our knowledge, this is the
first study to directly elicit these utilities for this pop-
ulation. We hypothesized that significant differences
would exist between adolescent and parent preferences
for key health states associated with T2DM and that
race/ethnicity would be independently associated with
adolescent and parent preferences.
Methods
Subjects
Subjects were adolescents between 12 and 18 yr of
age with BMI for age ≥85th percentile within the
prior 2 yr and T2DM, prediabetes, or IR along with a
parent. Parent and child had to be fluent in English or
Spanish. Adolescents were excluded for depression or
other psychiatric disorders (other than attention deficit
disorder); impaired cognitive skills or developmental
delay if functioning below a 6th grade academic level
by parent report; significant organ system illness;
hospitalization within the prior 6 months for a non-
diabetes-related chronic illness; pregnancy or planned
pregnancy (for females); or parenthood. T2DM,
prediabetes, and IR diagnoses were clinical diagnoses
based on documentation in the medical record.
For prediabetes, the terms ‘prediabetes’, ‘impaired
fasting glucose’, or ‘impaired glucose tolerance’ were
acceptable. Alternatively, laboratory data consistent
with the prevailing American Diabetes Association
criteria were also accepted. This included fasting blood
glucose between 100 and 125 mg/dL and/or a 2-h
postprandial glucose in an oral glucose tolerance test
(OGTT) between 140 and 199 mg/dL (32). For IR,
the terms ‘insulin resistance’, ‘metabolic syndrome’,
and ‘hyperinsulinemia’ were accepted. Laboratory
data were accepted as alternatives and included
fasting insulin >16 μU/mL, insulin peak (post-OGTT
load) >150 μU/mL, or insulin level at 120 min of
OGTT >75 μU/mL (33–35). We did not require that
laboratory criteria be met for all subjects as screening
practices at sites varied, biochemical definitions for IR
are not well established, and our goal was to identify
patients perceived to be at heightened clinical risk of
T2DM from the perspective of the patient and parent.
Therefore, to be eligible, the parent also had to report
awareness of the child’s diagnosis of T2DM or their
risk for T2DM (for those with prediabetes or IR).
Subjects were recruited between April 2006 and
December 2007 from programs at Children’s Hospital
Boston and Joslin Diabetes Center treating adolescents
with or at risk of T2DM. Potentially eligible patients
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were identified through clinicians, billing records or
self-referral. Screening was in-person or by telephone.
Those not initially indicating interest through clinicians
or self-referral were sent a recruitment letter and
opt-out postcard. A total of 143 patients completed
screening. Of these, 99 (69.2%) were eligible and
80 (55.9%) were interested and enrolled. After
enrollment and informed consent/assent, 10 subjects
were withdrawn prior to interview because interviews
could not be scheduled (N = 4); they were no longer
interested (N = 3); or were subsequently found to be
ineligible (N = 3). The study was approved by the
Institutional Review Boards of Children’s Hospital
Boston and Joslin Diabetes Center.
Data collection
An in-person parent interview was followed by
an in-person child interview. Interviewers were
fluent in English and Spanish. All interviews were
audiorecorded, and a subset was reviewed by the first
author for quality control. The adolescent’s most recent
height and weight were abstracted from the clinical
record to calculate BMI. Demographic data, family
history, parent’s self-reported height and weight, and
adolescent’s treatment regimen were collected during
the parent interview.
Health preference assessment
Utilities, reported on a scale from 0 (dead) to 1
(perfect health), for seven hypothetical health states
related to T2DM and its treatments were assessed
by the SG method. The health states included three
health states with T2DM and no complications with
varying treatments (dietary treatment only, oral med-
ication, and insulin treatment) and four health states
focused on diabetes complications, all assuming treat-
ment with insulin. All health states included the same
standard description of diabetes self-management and
routine diabetes health maintenance visits. Health state
descriptions were developed based on literature review
and clinical experience. SG surveys were professionally
translated into Spanish using forward and back trans-
lation and piloted with five adolescent/parent dyads.
Adolescents valued their own current health over
the prior 4 wk and the T2DM health states. Parents
valued the adolescent’s current health over the prior
4 wk and the same T2DM health states for their
children. Using the SG method, the adolescent received
a choice of remaining in the specified health state
for the rest of his/her life or the option of a ‘magic
potion’ which had some chance (p) of curing his/her
problem and leaving him/her in perfect health but
with one side effect, a chance (1 − p) that it may
instead cause immediate painless death. The parent
answered the same questions but with a ‘magic potion’
with either a chance (p) of curing their child’s health
state, leaving the child in perfect health, or a chance
(1 − p) of their child’s immediate painless death.
Based on each response, interviewers utilized a written
structured algorithm based on the bisection approach
to determine the next gamble to offer in order to
identify the respondent’s point of indifference, i.e., the
point when the respondent was indifferent between
the health state and the gamble (12). The value of the
health state was then ‘p’ at this point. For example,
if the adolescent could not decide between a lifetime
in the specified health state and accepting a ‘magic
potion’ with a 30% chance of his/her immediate painless
death to avoid a lifetime in the specified health state,
then the utility for that health state was 0.70 (i.e.,
1–0.30). Interviewers confirmed any valuations offered
by the respondent during the interview with a standard
statement. After rating all health states, respondents
were also given the opportunity to change their rating
of prior health states. Health state descriptions and
visual aids used to demonstrate the chances (p) were
presented in a booklet during the interview (see
Appendix S1, Supporting Information). At the end
of the interview, interviewers rated the respondent’s
comprehension of the SG on a 4-point likert scale (1 =
very good, 4 = limited). SG results considered invalid
by the interviewer because of limited comprehension
were excluded (N = 3 adolescents, N = 2 parents).
Various forms of bias may be introduced in the SG
interview process (12). To avoid anchoring bias, there
were three starting points for the algorithm: a 25, 50, or
75% chance of perfect health. To avoid an order effect,
there were two orderings of the health states. Dyads
were randomized to one of the six versions at the start
of the interview. To avoid framing bias, health states
were titled only with a letter rather than a medical
description (e.g., Health State A) and both the positive
and negative aspects of each gamble were presented
(i.e., the chance of the child’s perfect health and of the
child’s immediate painless death).
Utility for the adolescent’s current health over the
prior4wkwasalsoself-andparent-proxyassessedusing
the interviewer-administeredHealthUtilities Index(HUI),
a preference-based, generic measure of health-related
quality of life (36). The HUI3 classification system,
which includes the attributes of vision, hearing, speech,
ambulation, dexterity, emotion, cognition, and pain,
was then used to calculate the HUI3 multi-attribute util-
ity score for the adolescent’s current health (36).
Analysis
Adolescent and parent utilities for the seven T2DM
health states were measured by the SG. Adolescent
and parent utilities for the adolescent’s current health
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in the prior 4 wk were measured with the SG and
the HUI3 multi-attribute utility score (36). Results are
presented as medians with interquartile range (IQR).
Comparison of the adolescent/parent dyad outcomes
used the Wilcoxon signed-rank test. Differences in
adolescent and parent preferences according to base-
line characteristics were assessed using anova, t-test,
Pearson correlation, or comparable non-parametric
test, as appropriate. Spearman correlation coefficient
compared adolescent and parent utilities for the ado-
lescent’s current health assessed by SG and HUI.
There were 18 outcomes (i.e., seven T2DM health
states assessed by both adolescent and parent and
the adolescent- and parent-reported assessments of the
adolescent’s current health using both the SG and
HUI). Using a critical p-value of ≤0.03, the expected
number of type I errors is less than one half.
BMI percentiles were based on the Centers for Dis-
ease Control and Prevention growth charts (37). BMI
z-scores were calculated using EpiInfo™ version 3.3.2.
SAS version 9.1 (Cary, NC) was used for analyses.
Results
Study sample
Adolescents and parents completed surveys during
an interview that averaged 33.7 ± 4.7 min and
55.5 ± 14.7 min, respectively. Ten percent of the 69
parents completed the surveys in Spanish, and all
70 adolescents completed the surveys in English. SG
and HUI analyses each included 66 adolescents and
65 parents. Characteristics of the participants are
summarized in Table 1. Almost half (48.6%) of the
adolescents had a BMI > 99th percentile. T2DM,
prediabetes, and IR were almost equally represented.
For those with T2DM, 9.5% were treated with diet
alone; 28.6% oral medication and diet; 9.5% insulin
and diet; 38.1% oral medication, insulin, and diet; 4.8%
insulin alone; and 4.8% oral medication and insulin
(4.8% unknown). Oral medication with or without diet
was used among 19.1% of those with prediabetes and
14.3% of those with IR.
The parents (83% mothers) had an average age of
45.1 ± 7.3 yr and most had at least some college or
technical school education (N = 52, 75%). Parents had
a mean BMI of 32.9 ± 8.1 kg/m2, and almost a quarter
had T2DM (N = 16, 23%). On a 5-point Likert scale
ranging from 1 (poor) to 5 (excellent), 29% (N = 20) of
parents rated their own current health as poor or fair
and 13% (N = 9) rated their health as excellent.
Adolescent vs. parent preferences for T2DM health
states
Adolescent and parent preferences for the seven T2DM
health states and adolescent’s current health appear in
Table 1. Characteristics of adolescent subjects (N = 70)
Total
N = 70
Male
N = 23
Female
N = 47
Age, yr 15.5 ± 2.2 15.9 ± 2.0 15.3 ± 2.2
Age at diagnosis, yr 13.2 ± 2.6 13.4 ± 2.6 13.0 ± 2.6
BMI z-score 2.2 ± 0.6 2.4 ± 0.5 2.1 ± 0.6
BMI percentile
<95th 13 (18.6) 2 (8.7) 11 (23.4)
95th to 99th 23 (32.9) 7 (30.4) 16 (34.0)
>99th 34 (48.6) 14 (60.9) 20 (42.6)
Race/ethnicity
Hispanic (any race) 13 (18.6) 3 (13.0) 10 (21.3)
Non-Hispanic White 28 (40.0) 17 (73.9) 11 (23.4)
Non-Hispanic Black 20 (28.6) 1 (4.4) 19 (40.4)
Other/unknown 9 (12.9) 2 (8.7) 7 (14.9)
Diagnosis
Type 2 diabetes 21 (30.0) 5 (21.7) 16 (34.0)
Prediabetes 21 (30.0) 6 (26.1) 15 (31.9)
Insulin resistance 28 (40.0) 12 (52.2) 16 (34.0)
Family history of diabetes
No/unknown 10 (14.3) 6 (26.1) 4 (8.5)
Yes 60 (85.7) 17 (73.9) 43 (91.5)
Data are mean ± standard deviation or N (%).
Fig. 1. Adolescents and parents rated T2DM with no
complications treated with diet as the most desirable
T2DM health state [median (IQR); adolescent 0.72
(0.54, 0.98) vs. parent 1.0 (0.88, 1.0)] and end-stage
renal disease (ESRD) as the least desirable T2DM
complication [adolescent 0.51 (0.31, 0.70) vs. parent
0.8 (0.65, 0.94)]. Adolescents’ utilities were significantly
lower (p ≤ 0.001) than those of parents for all health
states assessed. The range of utility scores was wide
for both adolescents and parents although parent
responses were skewed toward higher utilities, and
adolescent utilities, particularly for complications,
were near normally distributed.
Adolescent and parent utilities for T2DM health
states did not differ significantly by child’s age,
race/ethnicity, or parent’s diagnosis of T2DM in
bivariate analyses. However, adolescents with any
family history of diabetes reported a significantly
higher median utility for oral medication [0.70 (0.56,
0.91) vs. 0.50 (0.42, 0.56), p = 0.001] and for insulin
treatment [0.72 (0.54, 0.88) vs. 0.50 (0.45, 0.6),
p = 0.007] compared to those without a family history.
Similarly, adolescents with parents who had at least
some college/technical school education reported a
significantly higher median utility for insulin [0.72
(0.60, 0.88) vs. 0.50 (0.24, 0.60), p = 0.003] and for
oral medication [0.72 (0.60, 0.91) vs. 0.54 (0.49, 0.62),
p = 0.005]. Treatment with insulin or oral medication
was not associated with a significant difference in
the utility for insulin or oral medication, respectively,
among either the adolescents or the parents. Increasing
adolescent BMI (as z-score) was associated with
higher adolescent utilities for blindness (p = 0.03)
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Diet Rx Oral Rx Insulin Rx ESRD Blind Amp CVD Current
Health 
0.72
0.54,0.98 
0.65
0.53,0.9
0.66
0.5, 0.85 
0.51
0.31,0.7
0.55
0.37,0.75 
0.56
0.44,0.75 
0.60
0.47,0.75 
0.82
0.51,1.0
A
B Diet Rx Oral Rx Insulin Rx ESRD Blind Amp CVD CurrentHealth 
1.0*‡
0.88, 1.0 
0.95§
0.82, 1.0 
0.94§
0.75, 1.0 
0.80‡
0.65, 0.94 
0.90§
0.75, 0.95 
0.90§
0.75, 0.97 
0.88‡
0.72, 0.95 
1.0*‡
0.86,1.0
Fig. 1. Type 2 diabetes health state preferences by standard gamble:
adolescent vs. parent/guardian. Data are median and interquartile
range. (A) Adolescent (N = 66). (B) Parent/guardian (N = 65).
*N = 64 because of missing data. Comparison of adolescent vs.
parent/guardian ‡p ≤ 0.001 §p < 0.0001. For comparison within
parent/adolescent dyads, eight dyads (nine for current health)
were excluded because either one or both of the standard gamble
interviews were incomplete or considered invalid because of limited
comprehension or improper administration. Diet Rx = type 2
diabetes with no complication and diet therapy; Oral Rx = type
2 diabetes with no complication and oral medication; Insulin Rx =
type 2 diabetes with no complication and insulin; ESRD = type 2
diabetes with end-stage renal disease; Amp = type 2 diabetes with
amputation; Blind = type 2 diabetes with blindness; CVD = type
2 diabetes and heart disease. All complication health states assume
treatment with insulin.
and heart disease (p = 0.02). After adjustment for
the child’s diagnosis, adolescent BMI z-score was
also associated with higher adolescent utility for
amputation (p = 0.03), and the other relationships with
T2DM complications remained significant. Although
adolescent utilities and most parent utilities did not
differ significantly by child’s diagnosis, we did find
that parents’ utility for blindness was lower among the
parents of adolescents with T2DM [T2DM mean (95%
CI) 0.63 (0.52, 0.75) vs. prediabetes 0.84 (0.72, 0.95)
vs. IR 0.84 (0.75, 0.94), p = 0.02]. Although parent
utilities were not associated with the adolescent’s BMI,
adjustment for adolescent’s BMI z-score strengthened
the significance of the relationship between the
adolescents’ diagnosis and the parents’ utility for
blindness [T2DM 0.61 (0.49, 0.73) vs. prediabetes
0.85 (0.73, 0.96) vs. IR 0.85 (0.76, 0.94), p = 0.006].
A similar relationship was observed with the parent
utilities for ESRD, heart disease, and amputation
although none achieved a p-value of 0.03. Parents’
preferences were not significantly different based on
family history of diabetes, their educational status, or
their self-rated health status.
Adolescent and parent utilities for child’s current
health
Adolescent- and parent-reported utility assessments
for the child’s current health are compared in Fig. 2.
The adolescent’s self-assessed utility for current health
was not correlated with the parent-proxy utility for
the adolescent’s current health using the SG (Fig. 2A)
and medians were significantly different [adolescent
0.82 (0.51, 1.0) vs. parent 1.0 (0.86, 1.0), p = 0.001]
(Fig. 1). Among the adolescents, there was no corre-
lation between their assessment of their current health
based on the SG and the HUI (Fig. 2B). Similarly,
there was no correlation between the parent-proxy
assessments of the adolescent’s current health using
these two methods (Fig. 2C).
Although the adolescents’ utility for their current
health based on the SG was not statistically different
based on their diagnosis (p = 0.23), ordering of utilities
increased in the expected direction with the lowest
median utility for current health among adolescents
with T2DM and the highest among those with IR
[T2DM 0.72 (0.50, 0.96) vs. prediabetes 0.82 (0.51,
1.0) vs. IR 0.95 (0.63, 1.0)]. A similar trend was
observed for the parent-reported utility for their
adolescent’s current health with the SG.
Discussion
As the prevalence of T2DM among youth increases, a
growing population of adolescents and young adults
will be utilizing T2DM treatments and managing its
chronic complications. In this study, we sought to
describe how adolescents with and at risk of T2DM
and their parents value these health states associated
with T2DM. Using the SG, we have derived adolescent
utilities for T2DM health states that can be used
in decision analysis models and economic analyses
that incorporate health-related quality of life (15).
Understanding how adolescents and their parents value
treatments and future health risks related to T2DM
can also facilitate shared decision-making (16). SG
interviews have been performed with adolescents with
a number of chronic health conditions (26–30, 38) but,
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A.
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C.
Fig. 2. Evaluation of adolescent’s current health. (A) Par-
ent/guardian standard gamble vs. child standard gamble (N = 61
dyads, r = 0.22, p = 0.09). Missing dyads because of incomplete or
invalid standard gamble interviews (N = 9). Symbols indicate child’s
diagnosis in (A) only. (B) Child standard gamble vs. child Health
Utilities Index (N = 63, r = 0.09, p = 0.49). Missing points because
of missing HUI data (N = 3) or invalid standard gamble interviews
(N = 4). (C) Parent/guardian standard gamble vs. Parent Health
Utilities Index (N = 60, r = 0.23, p = 0.08). Missing points because
of missing HUI data (N = 3), incomplete or invalid standard gamble
interviews (N = 5), or both (N = 1).
to our knowledge, this is the first study to target youth
with or at risk for T2DM.
On average, adolescents perceived T2DM complica-
tions and treatments to have significant negative impact
on health-related quality of life. However, utilities for
each health state were also quite heterogeneous. In
the SG, some adolescents were willing to accept high
risks of death to avoid even life with T2DM free of
complications and treated only with oral medication.
These responses may in part reflect adolescent perspec-
tives about mortality and attitudes toward risk (23,
39). In the National Longitudinal Study of Adolescent
Health (Add Health), for example, 14.7% of adoles-
cents reported at least a 50/50 chance that they would
not live to age 35, and perception of a high risk for
early death was associated with high risk behaviors and
outcomes such as drug use and suicide (40).
Adolescents in this study rated all assessed chronic
sequelae of diabetes significantly worse than their par-
ents rated them. Based on median utilities, adolescents
also ranked diabetes complications differently than
their parents except that both identified ESRD as the
least desirable T2DM complication. Few studies have
compared child and parent-proxy utilities for the same
health states, and the findings are heterogeneous (41).
However, some using the SG have demonstrated
child–parent differences (28, 38). Adolescents capable
of understanding the SG task may provide a unique
personal perspective, particularly with regard to the
social and emotional impacts of health states, that
may not be captured by a proxy-assessment (23, 25).
Parent-proxy valuations may also be affected by the
experiences of the parent (25). These issues underscore
some of the potential problems with using parent-
proxy preferences to guide medical decision-making
for children and adolescents.
Among the most worrisome associations that
we observed was the positive association between
increasing adolescent BMI and positive perception
of diabetes complications, suggesting that those with
increasing risk of such complications may either not
acknowledge this risk (i.e., denial), may be willing to
accept this risk, or possibly perceive such outcomes to
be unavoidable. The latter may make these adolescents
less willing to take risks in the SG. Prior work among
adolescents with T2DM supports the presence of denial
with respect to diabetes complications among some
of these youth (42). Additional research from Add
Health has also demonstrated that approximately one
third of obese adolescents were not perceived to be
obese by either themselves or their parent (43). Given
the heterogeneity in preferences we observed for the
T2DM health states, especially for complications, these
findings suggest that traditional prevention messages
may not be uniformly successful in this population,
and management discussions with every family likely
need to be tailored to their individual needs and
circumstances.
Although we did not find differences based on
race/ethnicity, the family context was found to
influence adolescent perceptions of T2DM treatments.
Specifically, a family history of diabetes was associated
with higher utilities (i.e., more desirable perception)
for medications to treat T2DM among adolescents.
Given that children and adolescents with and at
risk of T2DM are likely to come from families
also challenged by obesity and T2DM (44, 45),
it is not surprising that family history influences
perceptions of care. Those with a family history
may be willing to accept more aggressive treatments
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because of familiarity with and desire to avoid diabetes
complications or these youth may view having diabetes
as inevitable and their preference for more aggressive
therapy may reflect their familiarity with treatments.
Other studies have demonstrated higher utilities for
health states among those familiar with the health
state (20). Although our data do not allow us to
differentiate between these explanations, focus groups
with adolescents with T2DM have highlighted that
when family members with diabetes have demonstrated
poor self-management leading to complications, it has
prompted adolescents to have greater focus on self-care
behaviors (42). Rothman et al. have also shown that
family history of diabetes was not associated with poor
glycemic control in adolescents with T2DM (6). In
contrast, family history of diabetes was not associated
with parent-proxy preferences for adolescent health
states in our study. In focus groups with parents of
adolescents with T2DM, Mulvaney et al. found that
family history of diabetes was also not clearly viewed
as positive or negative with respect to its impact on
adolescent diabetes self-care behaviors (46). However,
in our sample, parent but not adolescent utilities for
T2DM complications were influenced by the child’s
diagnosis. Specifically, parents of adolescents with
T2DM had significantly lower utility (i.e., less desirable
perception) for blindness than parents of adolescents
with either prediabetes or IR. As only 30% of the
adolescents in our sample already had T2DM, these
relationships warrant further exploration.
Differences observed between the SG and HUI
utilities for the adolescent’s current health further
underscore the importance of understanding the source
of utilities and their potential biases. The adolescent’s
self-assessed utilities for current health using the SG
and HUI were not correlated nor were the parent-
proxy assessed utilities for the adolescent’s current
health using the SG and HUI. Discordant results
between the SG and the HUI among youth have
been previously observed (26, 28, 47) and support
the suggestion that there may be differences in the
information or perspectives captured by these two
methods (25). The more highly skewed results of
the parent SG utilities suggest that parents’ risk
aversion (23), i.e., their unwillingness to risk their
child’s death, may limit the usefulness of parent-
proxy assessments of child utilities using the SG when
parents are required to risk the child’s death. The
SG valuations can also be influenced by the parent’s
and the child’s valuation of death, illness, and perfect
health (29). Although there is evidence to support the
reliability of SG measurements (27, 30), the stability of
preferences over time remains a question warranting
further study (14). In contrast, the HUI utility is a
generic instrument based on answers to more objective
questions describing domains of vision, hearing,
speech, ambulation, dexterity, emotion, cognition,
and pain (36). However, as parents are only able
to report on what they observe, this may miss
certain dimensions of health relevant to the child or
limit the range of pediatric valuations of subjective
aspects of the health experience (23, 25). The HUI
utilities are also calculated based on the preferences
reported by an adult referent population (36) that may
not be representative of the population studied (23).
Therefore, both methods have potential caveats.
In addition to the implications for clinical practice,
our findings also have implications for policy and
public health as we have demonstrated that adolescent
preferences for T2DM health states differ from
those of adults with diabetes (17, 20). Among adults
with T2DM and mean age of 63 yr, for example,
Huang et al. found median utility scores of 0.25 for
ESRD, 0.35 for blindness, 0.55 for lower extremity
amputation, and 0.75 for angina (20). As health
preferences may change over the life course (22, 23),
using the preferences of adults with T2DM may not
be appropriate for economic evaluations of treatment
options during childhood. Further, as direct valuation
of health states related to T2DM is feasible for
adolescents, use of the SG (or comparable method
of direct preference elicitation) may be necessary to
capture the breadth of the adolescent perspective.
Several limitations warrant comment. First, this was
a convenience sample from two institutions in the
Boston area including both adolescents at risk of
T2DM in addition to those with T2DM. Therefore,
the generalizability of our findings may be limited. Sec-
ond, for some, the SG may be cognitively challenging
(23, 48, 49). However, we facilitated the interview by
having a practice health state unrelated to diabetes as
well as logic checks at the start of the interview, allow-
ing the respondents to revise their earlier answers at the
end of the survey, and providing survey guides to assist
with explanation of the percentages. Further, fewer
than 5% of SG interviews were eliminated because of
perceived comprehension difficulties. In addition, our
parent sample, with 75% of adults having at least some
college or technical school, and our adolescent sam-
ple, all functioning at a minimum of the 6th grade
level, should not be more challenged than other ado-
lescent (27) and adult (10) populations in which this
methodology has been used. Our observed ranking of
utilities for current health in the expected direction
according to the adolescent’s diagnosis and the find-
ing that health states with diabetes complications were
viewed as less desirable than those without complica-
tions supports the face and construct validity of the SG
in this population.
The epidemic of childhood obesity and the earlier
onset of T2DM in youth make understanding youth
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perceptions of disease treatment and outcomes criti-
cally important if management of young people with
T2DM is to be successful. We found significant dif-
ferences between the values of adolescents and parents
for health states associated with T2DM as well as con-
siderable heterogeneity in both groups. Family-based
programs striving for a model of shared decision-
making must be sufficiently flexible to communicate
about the treatments and health risks related to T2DM
and to then address the variable and potentially con-
flicting perspectives of adolescents and their parents.
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